Clinical Management of Major Depressive Disorder

CNS Spectrums

Volumn 14, Issue S10, 2009, Pages 3-6

  Mignon, Laurence ^a   Stahl, Stephen M ^b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; COGNITIVE THERAPY; HUMAN; MAJOR DEPRESSION; METHODOLOGY; PSYCHOLOGICAL ASPECT;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 77951904104     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900003837     Document Type: Article

References (23)

1. Rubinow, DR. Treatment strategies after SSRI failure--good news and bad news. N Eng J Med. 2006; 354(12):1305–1307.
2. Warden, D, Rush, AJ, Trivedi, MH, Fava, M, Wisniewski, SR. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007; 9(6):449–459.
3. Stahl, SM. Stahl's Essential Psychopharmacology. 3rd ed. New York, NY: Cambridge University Press; 2008.
4. Rapaport, MH. Beyond acute treatment of depressive disorders. J Clin Psychiatry. 2009; 70(7):e21.
5. Pompili, M, Serafini, G, Del Casale, A., et al, Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk. Exeprt Rev Neurother. 2009; 9(7):985–1004.
6. Nierenberg, AA, Husain, MM, Trivedi, MH., et al, Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2009: 1–10.
7. Berk, M. Sleep and depression - theory and practice. Aust Fam Physician. 2009; 38(5):302–304.
8. Fava, M, McCall, WV, Krystal, A., et al, Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006; 59(11):1052–1060.
9. Stahl, SM. Combining antidepressant therapies form the initiation of treatment: a paradigm shift for major depression. J Clin Psychiatry. In press.
10. Kurian, BT, Greer, TL, Trivedi, MH. Strategies to enhance the therapeutic efficacy of antide-pressants: targeting residual symptoms. Expert Rev Neurother. 2009; 9(7):975–984.
11. Clark, L, Chamberlain, SR, Sahakian, BJ. Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci. 2009; 32: 57–74.
12. Kaplan, KA, Harvey, AG. Hypersomnia across mood disorders: a review and synthesis. Sleep Med Rev. 2009; 13(4):275–285.
13. Baldwin, DS, Papakostas, GI. Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry. 2006; 67(suppl 6):9–15.
14. Kroenke, K, Krebs, EE, Bair, MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009; 31(3):206–219.
15. Shansky, RM. Estrogen, stress and the brain: progress toward unraveling gender discrepancies in major depressive disorder. Expert Rev Neurother. 2009; 9(7):967–973.
16. Zender, R, Olshansky, E. Women's mental health: depression and anxiety. Nurs Clin North Am. 2009; 44(3):355–364.
17. Stahl, SM. Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode. J Clin Psychiatry. 2009; 70(1):11–12.
18. Stahl, SM. Vasomotor symptoms and depression in women, part 2. Treatments that cause remission and prevent relapses of major depressive episodes overlap with treatments for vasomotor symptoms. J Clin Psychiatry. 2009; 70(3):310–311.
19. Laurent, SM, Simons, AD. Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension. Clin Psychol Rev. 2009; 29(7):573–585.
20. Koreman, SG. Epidemiology of erectile dysfunction. Endocrine. 2004; 23(2–3):87–91.
21. Conway, KP, Compton, W, Stinson, FS, Grant, BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006; 67(2):247–257.
22. Prager, LM. Depression and suicide in children and adolescents. Pediatr Rev. 2009; 30(6):199–205.
23. Blier, P, Gobbi, G, Turcotte, JE., et al, Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. Eur Neuropsychopharmacol. 2009; 19(7):457–465.